Pharmaceuticals, Biotechnology and Life Sciences
Boca Raton, FL, Sept. 27, 2021 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company…
With the launch of “Unlocking Growth – Powered by Biotech” Novozymes presents its 2025-strategy. It sets out an organic sales…
Please read the full announcement in PDF Attachment 2021_46_Novozymes_announces_ 2025_strategy
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”), announced today that it will participate…
LONDON, Sept. 27, 2021 (GLOBE NEWSWIRE) — On 20 August 2021, Tiziana Life Sciences Plc (“Old Tiziana”) announced that it…
NANTES, France, Sept. 27, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announced that it will host…
PALM BEACH GARDENS, Fla., Sept. 27, 2021 (GLOBE NEWSWIRE) — Accelus, a privately held medical technology company focused on accelerating…
SAN DIEGO, CA, Sept. 27, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical…
OCALA, Fla., Sept. 27, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced the filing of a…
REDWOOD CITY, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting…